MENU
ORIC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Oric Pharmaceuticals (ORIC) Ownership - Who owns Oric Pharmaceuticals?
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
240 E. Grand Avenue
Phone
+1 650 388-5600
Employees
100
Web
https://www.oricpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
370.76M
P/E Ratio
N/A
Total Cash
255.96M
Projected Growth
N/A
Total Debt
3.18M
Revenue
N/A
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash/Share
3.60
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ORIC
Capitalization
371M
P/E Ratio
N/A
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash
256M
Total Cash/Share
3.60
Total Debt
3.18M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
243M
P/B Ratio
1.53
Cash Flow
N/A
Earnings
-1.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
10.56
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-141.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.60
Shares Held By Institutions
732M
Shares Outstanding - Current
71M
Total Liabilities
31M
Total Volume MTD
N/A
Value
1
Gain YTD
-35.936
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
240 E. Grand Avenue
Phone
+1 650 388-5600
Employees
100
Web
https://www.oricpharma.com